≡ Search

logo - Farma Industria Ticino

  • Home
  • About
  • Members
  • Education
  • News
  • Events
  • Contact
  • Links
  • Jobs
  • Media center
  • IT

Main activities

  • Licensing-In
  • Licensing-Out
  • Co-development
  • Trading
  • Drug Product CMO
  • Drug Substance CMO
  • Other CMO Activities

Other activities

  • Analytical Services
  • Cosmetics
  • Distribution
  • Feed Additives
  • Flavours and Fragrances
  • Medical Devices
  • Medical Food
  • Natural Products
  • Nutraceuticals
  • Pre-formulation

Media center

Helsinn Investment Fund Invests €1 Million in Gain Therapeutics

19 February 2019

Alla ricerca di talenti

12 February 2019

Helsinn Provides Educational Grant for ESMO’s Preceptorship for Supportive and Palliative Care

31 January 2019

Wound Care: new clinical data show Nexodyn® AOS To reduce reinfections and healing time in diabetic foot ulcers

31 January 2019

Gabriel Haering at the Career Chat c/o ETH Zurich

17 January 2019

Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat

21 December 2018

RECORDATI AND HELSINN AGREEMENT FOR THE EXCLUSIVE COMMERCIALIZATION RIGHTS TO LEDAGA®

20 December 2018

Helsinn Group Announces new Permanent J Code for AKYNZEO® (fosnetupitant and palonosetron) for injection in the US

12 December 2018

Wound care: Nexodyn® AOS comes to fruition in Slovakia

12 December 2018

La farmaceutica ticinese a Madrid per la CPhI 2018

28 November 2018

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. »
  9. Last

Progetto Talenti

Also on:
Linkedin
  • Home
  • The FIT
  • Members
  • News
  • Events
  • Education
  • Contact
  • Restricted area

©2019 Farma Industria Ticino

Made by plastical

Loading...